Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086736
Status:
COMPLETED
Last Update Posted:
2013-11-19
First Post:
2004-07-08
Brief Title:
Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone Bicalutamide Alone and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy
Sponsor:
University of Alabama at Birmingham
Organization:
University of Alabama at Birmingham
Organization Data
Organization:
University of Alabama at Birmingham
Class:
OTHER
Study ID:
CDR0000353198
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Alabama at Birmingham
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |